Myriad Genetics and SimonMed® Imaging are partnering with

SALT LAKE CITY, Apr. 12, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ:MYGN), a pacesetter in genetic trying out and precision drugs, and SimonMed® The imaging corporate, some of the greatest suppliers of impartial scientific imaging products and services to outpatients and radiology doctor practices in the US, lately introduced the release of a brand … Read more